jenny mollen glp 1 details 'horror movie' side effects of GLP-1 drug: 'Blood everywhere' Exclusive | Jenny Mollen: Addiction

GLP-1s are medical treatments, not cosmetic shortcuts, and are comparable to bariatric surgery in their medical purpose

In a November 4, 2024, press release, the company highlighted preliminary DIO model data: "[P]eripherally-restricted nimacimab achieve[d] significant dose-dependent weight loss" and "[p]reliminary data shows that nimacimab achieves desired metabolic outcomes." Three days later, CEO Dhillon reinforced this on an earnings call: "We believe nimacimabs first-in-class profile as a perfectly targeting CB1 inhibitor offers the right combination of efficacy and safety." The Q3 2024 10-Q echoed the theme, touting nimacimab's potential to "positively impact metabolic disorders including obesity." This optimism escalated

But they address several of the metabolic and inflammatory factors that make living with Hashimoto's so difficult

Pricing starts at 29.99 per pack as displayed on the brand's official website

(120 ) , ,

Some clinicians who are aware of the allodynia risk recommend extended escalation timelines, particularly for patients approaching the 2.4 mg dose